Literature DB >> 1385606

The N-terminus and C-terminus of IFN-gamma are binding domains for cloned soluble IFN-gamma receptor.

N D Griggs1, M A Jarpe, J L Pace, S W Russell, H M Johnson.   

Abstract

The mechanism of binding of murine IFN-gamma to its receptor has not been determined. We have studied this mechanism by examining the binding of overlapping synthetic peptides of IFN-gamma to cloned soluble murine IFN-gamma R. IFN-gamma (1-39) and IFN-gamma (95-133) were able to compete with [125I]IFN-gamma for binding to cloned soluble receptor. Peptides corresponding to the inner region of IFN-gamma--IFN-gamma (36-60), IFN-gamma (54-91), and IFN-gamma (78-107)--showed a markedly reduced ability to compete with [125I]IFN-gamma for receptor binding relative to the N-terminal and C-terminal peptides. In direct binding studies, the binding of [125I]-IFN-gamma (1-39) to soluble receptor could only be competed by IFN-gamma (1-39) and IFN-gamma and not by any of the other peptides including IFN-gamma (95-133). This suggests that the N- and C-termini of IFN-gamma bind to different regions of the receptor. These data in conjunction with previous structure/function studies and x-ray crystallographic data have allowed us to formulate a "velcro-key" model of IFN-gamma binding to receptor that involves both the N- and C-terminal domains. The N-terminus binds in the classical "lock-and-key" manner characterized by specific ligand-receptor binding. The hydrophilic C-terminus binds to a region of the receptor distinct from the N-terminus likely through the polycationic region, which is conserved across species barriers. Binding of this type would exhibit high affinity and low specificity similar to a piece of velcro. This interaction becomes specific when the C-terminus is in the context of the whole IFN-gamma molecule and may act to increase the affinity of receptor binding and/or facilitate signal transduction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385606

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice.

Authors:  Christine M Fam; Stephen P Eisenberg; Sharon J Carlson; Elizabeth A Chlipala; George N Cox; Mary S Rosendahl
Journal:  J Interferon Cytokine Res       Date:  2014-05-19       Impact factor: 2.607

2.  Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis.

Authors:  P C Melby; V V Tryon; B Chandrasekar; G L Freeman
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Identification of functional domains on human interleukin 10.

Authors:  B Gesser; H Leffers; T Jinquan; C Vestergaard; N Kirstein; S Sindet-Pedersen; S L Jensen; K Thestrup-Pedersen; C G Larsen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 4.  Structural conservation of interferon gamma among vertebrates.

Authors:  Ram Savan; Sarangan Ravichandran; Jack R Collins; Masahiro Sakai; Howard A Young
Journal:  Cytokine Growth Factor Rev       Date:  2009-03-05       Impact factor: 7.638

5.  Molecular organization of the interferon gamma-binding domain in heparan sulphate.

Authors:  H Lortat-Jacob; J E Turnbull; J A Grimaud
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

6.  Cloning, expression and antiviral activity of IFNγ from the Australian fruit bat, Pteropus alecto.

Authors:  Vijaya Janardhana; Mary Tachedjian; Gary Crameri; Chris Cowled; Lin-Fa Wang; Michelle L Baker
Journal:  Dev Comp Immunol       Date:  2011-11-07       Impact factor: 3.636

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.